Search

everythinglearnresearchcommunity

for

Search:↓

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Estrogen and its receptors play a key role in hair growth, with differences between males and females.

High testosterone increases heart disease risk in women with PCOS.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Both estrogens and androgens are important for health in both males and females.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

SHBG may be a useful early indicator and treatment target for PCOS.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.